Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

Dcona MM, Damle PK, Zarate-Perez F, Morris BL, Nawaz Z, Dennis MJ, Deng X, Korwar S, Singh SJ, Ellis KC, Royer WE, Bandyopadhyay D, Escalante C, Grossman SR.

Mol Pharmacol. 2019 Jul;96(1):99-108. doi: 10.1124/mol.118.114363. Epub 2019 Apr 29.

PMID:
31036695
2.

CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.

Dcona MM, Morris BL, Ellis KC, Grossman SR.

Cancer Biol Ther. 2017 Jun 3;18(6):379-391. doi: 10.1080/15384047.2017.1323586. Epub 2017 May 22. Review.

3.

Light induced drug release from a folic acid-drug conjugate.

Dcona MM, Sheldon JE, Mitra D, Hartman MC.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):466-469. doi: 10.1016/j.bmcl.2016.12.036. Epub 2016 Dec 18.

4.

Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

Sheldon JE, Dcona MM, Lyons CE, Hackett JC, Hartman MC.

Org Biomol Chem. 2016 Jan 7;14(1):40-9. doi: 10.1039/c5ob02005k. Epub 2015 Oct 27.

5.

A new, highly water-soluble, fluorescent turn-on chemodosimeter for direct measurement of hydrogen sulfide in biological fluids.

Hartman MC, Dcona MM.

Analyst. 2012 Nov 7;137(21):4910-2. doi: 10.1039/c2an35870k. Epub 2012 Sep 10.

6.

Photocaged permeability: a new strategy for controlled drug release.

Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MC.

Chem Commun (Camb). 2012 May 16;48(39):4755-7. doi: 10.1039/c2cc30819c. Epub 2012 Apr 4.

Supplemental Content

Loading ...
Support Center